Leads, Technologies and Clinical Trials for New TB Drug Regimens

The 2021 Conference on Tuberculosis Drug Discovery and Development will explore recently developed leads, technologies and approaches to clinical trials that can be leveraged together to develop novel TB drug regimens. The conference will examine how recently gained understanding of TB biology may be coupled to greatest effect with drug discovery methods to identify leads and regimens with potential against TB. In addition, the conference will review the potential of new technologies and trial innovations to identify improved drug regimens. Host-directed therapies and non-traditional approaches will be included.

We invite researchers interested in all aspects of drug discovery and development and welcome participants from academia, industry, government and non-governmental organizations. In particular, we invite trainees and scientists from TB-endemic countries to apply, as their contribution to the struggle against TB is especially important. All participants are asked to submit abstracts of their work for presentation as posters, and some abstracts will be chosen for oral presentations. The conference provides the opportunity to interact with colleagues in an informal and intimate atmosphere and is designed to promote extensive discussion. In the past, the meeting has been oversubscribed – please apply early!